MktsMarkets

Aethlon Medical, Inc.
NASDAQ: AEMDKey statistics
AEMD News
Stories mentioning AEMD from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 561.00 | 533.00 | 294.00 | 524.00 | 1,296 | 240.00 | 261.00 | 415.00 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 1,930 | 2,062 | 1,510 | 1,792 | 2,003 | 1,815 | 2,902 | 2,621 |
| Operating Income (Loss) | (1,930) | (2,062) | (1,510) | (1,792) | (2,003) | (1,815) | (2,902) | (2,621) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (6.00) | 0.00 | ||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (1,884) | (2,018) | (1,487) | (1,762) | (6,255) | (1,755) | (2,807) | (2,571) |
| Earnings Per Share (Basic) | (2.80) | (2.45) | (3.74) | (0.85) | (40.10) | (10.05) | (16.11) | (2.76) |
| Earnings Per Share (Diluted) | (2.80) | (2.45) | (3.74) | (0.85) | (40.10) | (10.05) | (16.11) | (2.76) |
| Weighted Average Shares Outstanding (Basic) | 674.00 | 823.00 | 398.00 | 2,076 | 156.00 | 175.00 | 174.00 | 932.00 |
| Weighted Average Shares Outstanding (Diluted) | 674.00 | 823.00 | 398.00 | 2,076 | 156.00 | 175.00 | 174.00 | 932.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AEMD
Aethlon Medical, Inc. (NASDAQ: AEMD) is a stock listed on the Nasdaq Stock Market under the ticker symbol AEMD. It last traded at $4.84 (Nov 19, 2026, 4:00 PM ET), down 5.3% on the day. That gives Aethlon Medical a market capitalisation of $8.0M.
Over the past 52 weeks AEMD has traded between $1.41 and $25.20.
For the quarter ended Mar 31, 2026 it reported a net loss of $1.9M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$1.9M |
| Dec 31, 2025 | — | -$2.0M |
| Sep 30, 2025 | — | -$1.5M |
| Jun 30, 2025 | — | -$1.8M |
From Aethlon Medical’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…